Indoco Remedies P/B Ratio
Indoco Remedies (INDOCO) P/B ratio is 1.96 (Moderate), book value per share ₹494.21 vs Healthcare average P/B of -0.33 — Moderate - Reasonably valued relative to book value. Compare with Indoco Remedies valuation methods to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
INDOCO P/B Ratio — Valuation Insights & Book Value Analysis
Indoco Remedies price-to-book ratio interpretation, valuation status and historical context — current P/B 1.96 (Moderate). View INDOCO yearly price range for the annual high/low range and current price position.
- Current PB is 242.7% above historical average
- Trading at premium to sector average PB of -0.33
Indoco Remedies P/B Ratio Historical Trend
INDOCO annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see INDOCO stock price BSE.
INDOCO Historical P/B Ratio — Book Value Per Share & Year-End Price
Indoco Remedies annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.41 | ₹494.21 | ₹204.00 | ₹939 | Low |
| 2025 | 0.41 | ₹565.56 | ₹234.60 | ₹1,018 | Low |
| 2024 | 0.54 | ₹617.22 | ₹332.20 | ₹1,111 | Low |
| 2023 | 0.69 | ₹571.11 | ₹395.20 | ₹1,028 | Low |
| 2022 | 0.81 | ₹502.78 | ₹406.65 | ₹905 | Low |
INDOCO vs Healthcare Peers — P/B Ratio Comparison
Indoco Remedies P/B 1.96 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |